• Mashup Score: 8
    Wolters Kluwer Health - 3 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Source: lww.com
    Categories: Latest Headlines, Neurology
    Tweet Tweets with this article
    • Profile photo of NeurologyToday
      NeurologyToday

      Cinpanemab, a human #monoclonalantibody, did not slow #Parkinsons progression, Dr. Anthony E. Lang reported at #MDSCongress. @JankovicJoseph says that may be because of the binding site of the drug. Read more. https://t.co/J1GkZ4YEKp @AANMember #neurotwitter https://t.co/2S41QIYF7g

  • Mashup Score: 0
    COVID-19 Roundup: Vaccine Mandates, Vitamin D, Monoclonal Antibodies Uptake, Diet and COVID-19 - 3 year(s) ago

    COVID-19 has made headlines this week, as President Joe Biden announced a nationwide vaccine mandate, vitamin D was investigated as a potential treatment for COVID-19, monoclonal antibody use was examined, and the role of diet in COVID-19 risk and severity was analyzed. Did you miss these important stories? Catch up with our short roundup.

    Source: Consultant 360
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Consultant360
      Consultant360

      COVID-19 has made headlines this week, as President Biden announced a nationwide #vaccinemandate, vitamin D was investigated as a potential treatment, #monoclonalantibody use was examined, and the role of diet in #COVID19 risk and severity was analyzed. https://t.co/MwhPfD9XJX

  • Mashup Score: 0
    Wolters Kluwer Health - 3 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Source: lww.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of JRheumatology
      JRheumatology

      #Rituximab Induced Serum Sickness -Avoiding a Rash Diagnosis https://t.co/Xf8RrnQhPP #vasculitis #immunology #immunotherapy #monoclonalantibody #sideeffect #drugreaction #allergy #autoimmmune #RheumTwitter #rheumatology #medtwitter https://t.co/0W8L9eeVMC

  • Mashup Score: 2
    Bamlanivimab Promising for COVID-19 Prevention in Long-Term Care Facilities - 3 year(s) ago

    Positive results were announced from a phase 3 trial evaluating bamlanivimab for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff of long-term care facilities.

    Source: Pulmonology Advisor
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of PulmAdvisor
      PulmAdvisor

      Positive results were announced from a phase 3 trial evaluating #bamlanivimab, a potent neutralizing IgG1 #monoclonalantibody, for the prevention of #SARS-CoV-2 infection and #COVID-19 in residents and staff of #long-term care facilities. Read More: https://t.co/PGobcPKSso

  • Mashup Score: 2
    Therapeutics Distribution - 3 year(s) ago

    Therapeutics Distribution The national map below displays those locations that have received shipments of monoclonal antibody therapeutics under the U.S. Food and Drug Administration Emergency Use Authorization (EUA) authority, within the past several weeks.  The monoclonal antibodies treatments Bamlanivimab (made by Eli Lilly and Company) and the therapeutic cocktail Casirivimab/Imdevimab (made…

    Source: protect-public.hhs.gov
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DrRobertGlatter
      DrRobertGlatter

      RT @DrJudyStone: Why are most states hiding this #MonoclonalAntibody tracker? https://t.co/cURPKCqgaB #Transparency would help save lives @…

Load More